Development-stage medical device company Cerebain Biotech said today that it’s planning to begin development of a medical device designed to treat Alzheimer’s disease and dementia. The minimally invasive implantable device is designed for omentum stimulation, which the company said has a “clinically observable, positive impact” on cognitive function related to dementia and Alzheimer’s disease. The device can be adjusted […]